Semaglutide, a selective GLP-1 receptor agonist marketed as Ozempic, Wegovy, and Rybelsus, is one of the most extensively studied anti-obesity and anti-diabetes medications in history, with over 25,000 clinical trial participants and FDA approval for three distinct indications
The following ranges are sourced from GoodRx price data and manufacturer list prices, accurate as of the dates noted: Ozempic: GoodRx reports average retail pricing often around $1,000-$1,200+ per month without insurance (reviewed January 8, 2026)
Recent clinical trials show these medications may improve: Fatty liver disease (MASH) Cardiovascular health Metabolic disorders Inflammation Meanwhile, next-generation drugs like Retatrutide are producing nearly 29% average weight reduction in clinical studies while also improving knee osteoarthritis symptoms
Additionally, some may opt for complementary procedures like body contouring treatments or non-invasive fat reduction techniques
If the taste is problematic, do not try to mask it with food or drink before the 30-minute post-dose fasting window
